Fmoc-PEG4-NHS ester, 5g

((4R,5R)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)dimethanol, 95.0%, 5g

(S)-2-(3,4-difluorophenyl)oxirane, 95%, 5g

5-tert-butyl 2-ethyl 6,7-dihydrooxazolo[5,4-c]pyridine-2,5(4H)-dicarboxylate, 95+%, 500mg

1-(5-Chloro-pyrimidin-2-yl)-pyrrolidin-3-ol, 500mg

2-Methylpyridine-4-carbaldehyde, 97.0%, 250mg

4-Bromo-5-nitropyridin-2-amine, 95.0%, 10g

2-Amino-2-(2,6-difluorophenyl)acetic acid hydrochloride, 95.0%, 250mg

N-(4-Methyl-3-nitrophenyl)methanesulfonamide, 95+%, 1g

4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether, 97.0%, 25g

ethyl 3-amino-4-methoxy-1-benzothiophene-2-carboxylate, 1g

2,2'-Methylenebis[6-(1-methylcyclohexyl)-p-cresol]>95.0%(T)25g

2,6-Bis((R)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)pyridine, 98.0%, 5g